Application of Tumor Burden Score for predicting conversion outcome in patients with initially unresectable colorectal liver metastases after first-line systemic therapy

BACKGROUND: Patients with initially unresectable colorectal liver metastases (CRLM) could achieve survival benefit from successful conversion therapy. Recently, Tumor Burden Score (TBS) was proposed as a valuable index to predict outcome following resection of CRLM. The study is aimed to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Jianhong, Liu, Yujun, Li, Weihao, Lin, Yuzhu, Sun, Hui, Pan, Zhizhong, Wu, Xiaojun, Fan, Wenhua, Lin, Junzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721375/
https://www.ncbi.nlm.nih.gov/pubmed/34987612
http://dx.doi.org/10.1177/17562848211066206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721375/
https://www.ncbi.nlm.nih.gov/pubmed/34987612
http://dx.doi.org/10.1177/17562848211066206

Ejemplares similares